Pharmaceutical compositions and dosage forms

US11007191B2 · kind B2 · utility

Assignee

• Ignyta, Inc. · US

Inventors

• Robert ORR · San Clemente, US
• Kathryn Emily Colombo Pugh · Bend, US
• Matthew J. Shaffer · Bend, US
• Brent Antone Uhrig · Bend, US
• Edward Dennis LaChapelle · Bend, US
• Charlie Michael McLaughlin · Bend, US

Key dates

• Filing date: Apr 14, 2020
• Grant date: May 18, 2021
• Expiry date: Apr 14, 2040

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K9/48
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present disclosure relates to pharmaceutical compositions comprising N-[5-(3,5-difluorobenzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-2H-pyran-4-ylamino)-benzamide and a polymer, dosage forms comprising the formulation and methods of treating subjects having cancer.